Pharmaceutical Industry News
Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors
Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.
Consultants | 13/08/2020 | By Darshana | 115
Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals
Consultants | 09/07/2020 | By Darshana | 126
Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily
Thyrocare, India?s leading diagnostic laboratory chain, has announced the availability of ?COVID Antibody Test? to check your body?s response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past
Consultants | 05/07/2020 | By Darshana | 132
The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA?s Oncology Center of Excellence (OCE). Through a new website, Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials
Consultants | 24/06/2020 | By Darshana | 127
FDA Approves Drug to Treat Infants and Children with HIV
Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments
Consultants | 15/06/2020 | By Darshana | 113
Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday
Consultants | 26/05/2020 | By Darshana | 141
DRDO introduces two new products to enhance operations during COVID-19 disinfection process
The Defence Research and Development Organisation (DRDO) has introduced two products which can enhance the operations at public places during the COVID-19 disinfection process
Consultants | 19/04/2020 | By Darshana | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy